retatrutide heart arrhythmia A concern with a new obesity drug? #retatrutide #elililly Why some of my patients

I was able to get a vitamin D shot, have a treatment upstairs, get my vitals checked, and stock up on supplements in one afternoon

For a lot of us, food just shifts

Staying alert to such reactions helps patients, clinicians and regulators better understand the real-world safety of these medicines

Solomon SD, McMurray JJV, Claggett B, et al

In one clinical trial published in The New England Journal of Medicine in 2016, patients with obesity and type 2 diabetes lost an average of 10.8 pounds and lowered their A1C (a measurement of average blood sugar levels) by 1.4 percent after taking 1 mg of semaglutide for 104 weeks (8)